Ontology highlight
ABSTRACT:
SUBMITTER: Mistry H
PROVIDER: S-EPMC4089878 | biostudies-literature | 2013 Dec
REPOSITORIES: biostudies-literature
Mistry Helena H Hsieh Grace G Buhrlage Sara J SJ Huang Min M Park Eunmi E Cuny Gregory D GD Galinsky Ilene I Stone Richard M RM Gray Nathanael S NS D'Andrea Alan D AD Parmar Kalindi K
Molecular cancer therapeutics 20131015 12
Inhibitor of DNA binding 1 (ID1) transcription factor is essential for the proliferation and progression of many cancer types, including leukemia. However, the ID1 protein has not yet been therapeutically targeted in leukemia. ID1 is normally polyubiquitinated and degraded by the proteasome. Recently, it has been shown that USP1, a ubiquitin-specific protease, deubiquitinates ID1 and rescues it from proteasome degradation. Inhibition of USP1 therefore offers a new avenue to target ID1 in cancer. ...[more]